Ellen Warner

Surveillance of <EMPH TYPE="ITAL">BRCA1</EMPH> and <EMPH TYPE="ITAL">BRCA2</EMPH> Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast Examination

Ellen Warner · JAMA · 2004 · 1.2K citations

Medicine, Oncology, Radiology +15

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David Miles, Joseph Gligorov, Fabrice André et al. · Annals of Oncology · 2021 · 729 citations · Full text

Medicine, Oncology, Pharmacology +17

Contralateral Breast Cancer in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers

Kelly Metcalfe, Henry T. Lynch, Parviz Ghadirian et al. · Journal of Clinical Oncology · 2004 · 619 citations

Medicine, Oncology, Breast Oncology +15

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

Antonis C. Antoniou, Alex Cunningham, Julian Peto et al. · British Journal of Cancer · 2008 · 535 citations · Full text

Medicine, Genetics, Oncology +17

Comparison of Breast Magnetic Resonance Imaging, Mammography, and Ultrasound for Surveillance of Women at High Risk for Hereditary Breast Cancer

Ellen Warner, Donald B. Plewes, Rene Shumak et al. · Journal of Clinical Oncology · 2001 · 460 citations

Medicine, Radiology, Cancer Screening +16